Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Eye formulation administering system containing lecithin and sodium hyaluronic acid and its preparing method

A technology of sodium hyaluronate and drug delivery system, which is applied in the direction of medical preparations containing active ingredients, pharmaceutical formulas, and medical preparations with non-active ingredients. Difficult to blink etc.

Inactive Publication Date: 2005-07-06
凌沛学
View PDF0 Cites 12 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] At present, the shortcomings of artificial tears are: 1. It does not contain natural lipids, and there is a lack of artificial tears for the treatment of excessive tear evaporation type xerophthalmia
It can be seen that most of the current artificial tears cannot effectively treat dry eyes caused by the lack of lipid layer.
② Cannot simulate the three-layer structure of normal tear film
Although synthetic polymers can increase the viscosity of eye drops and prolong the residence time of the liquid in the eye to improve the curative effect, the synthetic polymers used are basically Newtonian fluids. When the viscosity increases to a certain extent, it will cause Eyelids do not blink easily and are irritating to the eyes

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Eye formulation administering system containing lecithin and sodium hyaluronic acid and its preparing method
  • Eye formulation administering system containing lecithin and sodium hyaluronic acid and its preparing method
  • Eye formulation administering system containing lecithin and sodium hyaluronic acid and its preparing method

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0043] The ophthalmic drug delivery system of the present invention comprises 0.1 gram of lecithin, 0.1 gram of sodium hyaluronate, 0.85 gram of sodium chloride, 0.05 gram of borax, 0.05 gram of vitamin E acetate, and the rest is purified water in 100 mL.

Embodiment 2

[0045] The ophthalmic drug delivery system of the present invention, in 100mL, contains 0.1 gram of lecithin, 0.1 gram of sodium hyaluronate, 0.75 gram of sodium chloride, 0.3 gram of propylene glycol, 800.3 gram of Tween, 0.05 gram of borax, 0.05 gram of vitamin E acetate, and the rest are purified water.

Embodiment 3

[0047] The ophthalmic drug delivery system of the present invention, in terms of 100 mL, contains 0.1 g of lecithin, 0.1 g of sodium hyaluronate, 0.75 g of sodium chloride, 0.3 g of propylene glycol, 800.3 g of Tween, 0.05 g of borax, 0.05 g of vitamin E acetate, and hydroxybenzene 0.03 g of ethyl ester, and the rest is purified water.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to an eye formulation administering system containing lecithin and sodium hyaluronic acid and its preparing method, wherein the system can directly serve as artificial tears to be applied to the treatment of xerophthalmia and other ophthalmology diseases. The system may also include other active constituents.

Description

Technical field: [0001] The invention relates to an ophthalmic drug delivery system containing lecithin (English: lecithin or phosphatidylcholine, also called phosphatidylcholine) and sodium hyaluronate (English: sodium hyaluronate, also called sodium hyaluronate) and a preparation method thereof. It belongs to the field of pharmaceutical technology. Background technique: [0002] Clinically, the dryness of the eyeball surface caused by the lack and abnormal distribution of tear film components is called xerophthalmia. Abnormalities in the lipid, aqueous, and mucus layers of the tear film, as well as abnormalities in the ocular surface, can cause xerophthalmia. The pathogenesis of xerophthalmia is complex. Among them, the lack of lipid layer is one of the main causes of xerophthalmia. There are many other causes of dry eye, such as aging, autoimmune diseases such as Sjogren's syndrome (Sjögren's syndrome), vitamin A deficiency, blocked lacrimal ducts, chronic conjunctivit...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/728A61K45/00A61K47/36A61P27/04
Inventor 凌沛学王凤山荣晓花陈翊
Owner 凌沛学
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com